Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 25601-25650 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06418581
Investigation on Burnout of Physicians
N/ARecruiting
500 participants
Started: Apr 19, 2024 · Completed: May 1, 2025
1 condition1 sponsor1 location
NCT06243393
Sacituzumab Govitecan in Metastatic Colorectal Cancer
PHASE2/PHASE3Recruiting
80 participants
Started: Apr 19, 2024 · Completed: Feb 1, 2029
1 condition1 sponsor1 location
NCT06159803
LIving BEtteR With asThma - Intervention Development Study
N/ARecruiting
50 participants
Started: Apr 19, 2024 · Completed: Nov 1, 2025
1 condition1 sponsor1 location
NCT05885529
Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin Carboxy-terminal Hydrolase L1 (UCH-L1) to Exclude Lesions Linked to Significant Traumatic Brain Injuries
N/ARecruiting
1,500 participants
Started: Apr 19, 2024 · Completed: Mar 30, 2026
1 condition15 sponsors15 locations
NCT05990751
Multi-modular Chimeric Antigen Receptor Targeting GD2 in Neuroblastoma
PHASE1Recruiting
12 participants
Started: Apr 19, 2024 · Completed: Dec 31, 2041
1 condition1 sponsor1 location
NCT06410300
Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy
N/ARecruiting
125 participants
Started: Apr 19, 2024 · Completed: Apr 19, 2030
1 condition2 sponsors3 locations
NCT06291961
A Safety and Efficacy Study Evaluating CS-101 in Subjects With β-Thalassemia Major
PHASE1Recruiting
8 participants
Started: Apr 18, 2024 · Completed: Jul 31, 2025
1 condition1 sponsor3 locations
NCT06399445
Measurement of Blood Loss in Adenotonsillectomy During General Anesthesia According to the Application of Nondepolarizing Muscle Relaxants
PHASE4Recruiting
60 participants
Started: Apr 18, 2024 · Completed: Oct 31, 2025
6 conditions1 sponsor1 location
NCT05823532
Anti-Inflammatory Challenge in Schizophrenia
PHASE4Recruiting
20 participants
Started: Apr 18, 2024 · Completed: Mar 31, 2028
1 condition2 sponsors2 locations
NCT06286501
Targeting of Preventive Treatment for Adolescents at Risk of Oral Diseases
NARecruiting
120 participants
Started: Apr 18, 2024 · Completed: Dec 31, 2025
4 conditions4 sponsors1 location
NCT06345586
Drospirenone Only Pills and Cervical Mucus Changes: A Pre- and Post-Bariatric Surgery Study
NARecruiting
16 participants
Started: Apr 18, 2024 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT05748197
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
PHASE1Recruiting
40 participants
Started: Apr 18, 2024 · Completed: Apr 18, 2028
1 condition2 sponsors7 locations
NCT06113003
The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease
EARLY_PHASE1Recruiting
63 participants
Started: Apr 18, 2024 · Completed: Mar 1, 2026
3 conditions1 sponsor1 location
NCT06213272
Combined Exercise and Targeted Therapy for Post-Stroke Reading Deficits
NARecruiting
70 participants
Started: Apr 18, 2024 · Completed: Mar 1, 2029
3 conditions1 sponsor1 location
NCT06418425
Exercise Program and Protein Intake Counselling for Frailty Prevention in Singapore
NARecruiting
240 participants
Started: Apr 18, 2024 · Completed: Apr 18, 2026
1 condition2 sponsors1 location
NCT05468931
Prostate Stimulation for Sexual Dysfunction
NARecruiting
15 participants
Started: Apr 18, 2024 · Completed: Jun 1, 2026
4 conditions1 sponsor1 location
NCT06424613
Effects of Lithium on Suicide Prevention in Adolescents and Young Adults With Bipolar Disorder in China
N/ARecruiting
600 participants
Started: Apr 18, 2024 · Completed: Dec 31, 2024
4 conditions2 sponsors1 location
NCT05963191
CAD-EYE System for the Detection of Neoplastic Lesions in Patients With Lynch Syndrome
NARecruiting
272 participants
Started: Apr 18, 2024 · Completed: Apr 18, 2026
1 condition1 sponsor1 location
NCT06349837
Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients with Bulky Tumors
PHASE1Recruiting
9 participants
Started: Apr 18, 2024 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT05984797
Integrated Short-Term Palliative Rehabilitation in Incurable Cancer
NARecruiting
340 participants
Started: Apr 18, 2024 · Completed: Aug 31, 2026
1 condition8 sponsors11 locations
NCT05325099
Demethylating Agent Azacitidine on Prevention of Acute Kidney Injury-chronic Kidney Disease Continuum
PHASE1/PHASE2Recruiting
60 participants
Started: Apr 18, 2024 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT06731426
Multi-session, Personalized Cognitive Bias Modification for Thought-Action-Fusion
NARecruiting
84 participants
Started: Apr 18, 2024 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT05452356
Testing VIRTUES Patient Care Sets in Cardiac Patients (VIRTUES Cardiac Care)
N/ARecruiting
2,000 participants
Started: Apr 18, 2024 · Completed: Sep 30, 2028
5 conditions2 sponsors1 location
NCT06906237
Scarless Advanced Breast Extended Oncoplasty: The ScarABEO Study
N/ARecruiting
250 participants
Started: Apr 18, 2024 · Completed: Dec 1, 2025
4 conditions1 sponsor1 location
NCT06573658
Neurophysiological Changes After Perturbation-based Training in Older Adults
NARecruiting
88 participants
Started: Apr 18, 2024 · Completed: Oct 14, 2026
5 conditions1 sponsor1 location
NCT06431529
A Study of Tumor Neoantigen-specific T Cells in the Treatment of Advanced Solid Tumors
EARLY_PHASE1Recruiting
6 participants
Started: Apr 18, 2024 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06320509
Interest of Urinary Oxygen Partial Pressure (PO2u) in Predicting the Onset or Recovery of Acute Renal Failure During Shock States - OXYpi Study
NARecruiting
55 participants
Started: Apr 18, 2024 · Completed: Jul 18, 2026
1 condition1 sponsor1 location
NCT06382883
Lifestyle and Physical Activity as Part Of Obstructive Sleep Apnea Treatment
NARecruiting
300 participants
Started: Apr 18, 2024 · Completed: Dec 31, 2027
1 condition4 sponsors1 location
NCT06156774
SARcopenia and Simplified Geriatric Assessment in Lymphoma Patients Undergoing CAR-T Cell Therapy: the FIL_SAR-CAR Project
N/ARecruiting
130 participants
Started: Apr 18, 2024 · Completed: Jul 31, 2026
1 condition2 sponsors21 locations
NCT06778681
Mechanism of Fatigue in Fibromyalgia and Cortical Motor Neuron Dysfunction
NARecruiting
36 participants
Started: Apr 18, 2024 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT06769529
Observational Cohort Study of Adult Patients With Congenital Heart Disease
N/ARecruiting
2,000 participants
Started: Apr 18, 2024 · Completed: May 1, 2025
1 condition1 sponsor1 location
NCT06293651
Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
125 participants
Started: Apr 18, 2024 · Completed: Oct 31, 2029
1 condition1 sponsor2 locations
NCT06304441
Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. 'Osimertinib') Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung Cancer
NARecruiting
100 participants
Started: Apr 18, 2024 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT06285422
Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID)
PHASE1Recruiting
35 participants
Started: Apr 18, 2024 · Completed: Mar 31, 2029
2 conditions1 sponsor3 locations
NCT05777603
Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-small Cell Lung Cancer
PHASE1Recruiting
23 participants
Started: Apr 18, 2024 · Completed: Jun 1, 2028
1 condition1 sponsor1 location
NCT06928376
"A Multicenter RCT of 3+7 vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients"
PHASE2Recruiting
160 participants
Started: Apr 18, 2024 · Completed: Oct 18, 2026
2 conditions8 sponsors1 location
NCT06164587
Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy
PHASE1/PHASE2Recruiting
30 participants
Started: Apr 18, 2024 · Completed: Dec 31, 2027
2 conditions2 sponsors9 locations
NCT06045754
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
PHASE4Recruiting
100 participants
Started: Apr 18, 2024 · Completed: Jun 28, 2027
1 condition1 sponsor54 locations
NCT05395598
Incidence of Major Complication in Case of Thoracic Aortic Aneurysm
N/ARecruiting
320 participants
Started: Apr 18, 2024 · Completed: Oct 31, 2031
1 condition4 sponsors1 location
NCT06334237
Psychosomatic Factors Influencing the Efficacy of Holistic Care for Migraine
N/ARecruiting
120 participants
Started: Apr 18, 2024 · Completed: Feb 21, 2026
1 condition1 sponsor1 location
NCT06319820
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
PHASE3Recruiting
560 participants
Started: Apr 18, 2024 · Completed: Jun 28, 2028
1 condition1 sponsor193 locations
NCT06049355
EMBRACE: Exercising Together
PHASE2Recruiting
400 participants
Started: Apr 18, 2024 · Completed: Sep 1, 2028
2 conditions3 sponsors1 location
NCT06902857
Study on the Predictive Value of High-sensitivity Cardiac Troponin I, N-terminal Pro-B-natriuretic Peptide, and Soluble Suppression of Tumorigenesis-2 for Mortality and the Development of Cardiovascular Events in Patients With Type 2 Diabetes (Diabetes-CV)
N/ARecruiting
1,002 participants
Started: Apr 18, 2024 · Completed: Dec 31, 2028
2 conditions1 sponsor1 location
NCT06332404
Hypoglossal Nerve Stimulation Therapy in Patients With Obstructive Sleep Apnea: Belgian Registry
N/ARecruiting
225 participants
Started: Apr 18, 2024 · Completed: Apr 30, 2034
3 conditions1 sponsor2 locations
NCT06288438
Multicomponent Telerehabilitation to Engage Veterans in Effective Self-Management of Complex Health Conditions
NARecruiting
126 participants
Started: Apr 18, 2024 · Completed: Mar 31, 2028
2 conditions1 sponsor1 location
NCT06473896
Effect of Ketalar or Dexmedetomidine on Increased Sensitivity to Pain Following Treatment With Remifentanil
NARecruiting
90 participants
Started: Apr 18, 2024 · Completed: Aug 30, 2026
1 condition1 sponsor1 location
NCT06732700
Effect of INIT on Cervical Proprioception in Patients With Forward Head Posture
NARecruiting
42 participants
Started: Apr 18, 2024 · Completed: Dec 22, 2024
1 condition1 sponsor1 location
NCT06217757
Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC
PHASE1/PHASE2Recruiting
45 participants
Started: Apr 18, 2024 · Completed: Mar 20, 2027
2 conditions1 sponsor1 location
NCT05637203
Study About Group and Phone Follow-Up After a Crisis
PHASE3Recruiting
100 participants
Started: Apr 18, 2024 · Completed: Apr 30, 2026
2 conditions2 sponsors2 locations
NCT06421909
Mindfulness-based Educational Intervention on Anxiety, Depression, Stress and Quality of Life on Menopausal Woman
NARecruiting
120 participants
Started: Apr 18, 2024 · Completed: Aug 28, 2024
1 condition1 sponsor1 location